APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hybrid Positron Emission Tomography (PET) Systems

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hybrid Positron Emission Tomography (PET) Systems Market Outlook and Growth Opportunities 2026

4 July 2026201 pages

Choose your research edition.

Industry ResearchHybrid Positron Emission Tomography (PET) Systems Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Hybrid Positron Emission Tomography (PET) Systems Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Hybrid Positron Emission Tomography (PET) Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hybrid Positron Emission Tomography (PET) Systems Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Hybrid Positron Emission Tomography (PET) Systems Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Hybrid Positron Emission Tomography (PET) Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hybrid Positron Emission Tomography (PET) Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hybrid Positron Emission Tomography (PET) Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hybrid Positron Emission Tomography (PET) Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hybrid Positron Emission Tomography (PET) Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hybrid Positron Emission Tomography (PET) Systems market include Agfa-Gevaert Group, Bruker, Canon Medical Systems Corporation, CMR Naviscan, Cubresa, FUJIFILM Holdings Corporation, General Electric, Hitachi and Koninklijke Philips, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hybrid Positron Emission Tomography (PET) Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hybrid Positron Emission Tomography (PET) Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hybrid Positron Emission Tomography (PET) Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hybrid Positron Emission Tomography (PET) Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Hybrid Positron Emission Tomography (PET) Systems Segment by Company

Agfa-Gevaert Group

Bruker

Canon Medical Systems Corporation

CMR Naviscan

Cubresa

FUJIFILM Holdings Corporation

General Electric

Hitachi

Koninklijke Philips

Mediso

MinFound Medical Systems

Oncovision

Rigaku

Siemens Healthcare

Neusoft Corporation

Medtronic

Abbott

Hybrid Positron Emission Tomography (PET) Systems Segment by Type

Direct Imaging

Alternative Imaging

Indirect Imaging

Hybrid Positron Emission Tomography (PET) Systems Segment by Application

Hospitals

Diagnostic Imaging Centers

Others

Hybrid Positron Emission Tomography (PET) Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hybrid Positron Emission Tomography (PET) Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hybrid Positron Emission Tomography (PET) Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hybrid Positron Emission Tomography (PET) Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Hybrid Positron Emission Tomography (PET) Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hybrid Positron Emission Tomography (PET) Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hybrid Positron Emission Tomography (PET) Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hybrid Positron Emission Tomography (PET) Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hybrid Positron Emission Tomography (PET) Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hybrid Positron Emission Tomography (PET) Systems industry.

Chapter 3: Detailed analysis of Hybrid Positron Emission Tomography (PET) Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hybrid Positron Emission Tomography (PET) Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hybrid Positron Emission Tomography (PET) Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hybrid Positron Emission Tomography (PET) Systems Industry Trends Table 2. Hybrid Positron Emission Tomography (PET) Systems Industry Drivers Table 3. Hybrid Positron Emission Tomography (PET) Systems Industry Opportunities and Challenges Table 4. Hybrid Positron Emission Tomography (PET) Systems Industry Restraints Table 5. Global Hybrid Positron Emission Tomography (PET) Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hybrid Positron Emission Tomography (PET) Systems Revenue Share by Company (2021-2026) Table 7. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Company (units) & (2021-2026) Table 8. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Company (2021-2026) Table 9. Global Hybrid Positron Emission Tomography (PET) Systems Average Price (USD/unit) of Company (2021-2026) Table 10. Global Hybrid Positron Emission Tomography (PET) Systems Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hybrid Positron Emission Tomography (PET) Systems Key Company Manufacturing Base & Headquarters Table 12. Global Hybrid Positron Emission Tomography (PET) Systems Company, Product Type & Application Table 13. Global Hybrid Positron Emission Tomography (PET) Systems Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hybrid Positron Emission Tomography (PET) Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Direct Imaging Table 18. Significant Companies of Alternative Imaging Table 19. Significant Companies of Indirect Imaging Table 20. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 21. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Type (2021-2026) & (units) Table 22. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Type (2027-2032) & (units) Table 23. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Type (2021-2026) Table 24. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Type (2027-2032) Table 25. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type (2021-2026) Table 29. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Diagnostic Imaging Centers Table 32. Significant Companies of Others Table 33. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 34. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Application (2021-2026) & (units) Table 35. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Application (2027-2032) & (units) Table 36. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Application (2021-2026) Table 37. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Application (2027-2032) Table 38. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application (2021-2026) Table 42. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application (2027-2032) Table 43. Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region: 2021 VS 2025 VS 2032 (units) Table 44. Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region (2021-2026) & (units) Table 45. Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Region (2021-2026) Table 46. Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region (2027-2032) & (units) Table 47. Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Region (2027-2032) Table 48. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Region (2021-2026) Table 51. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Region (2027-2032) Table 53. Global Hybrid Positron Emission Tomography (PET) Systems Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Hybrid Positron Emission Tomography (PET) Systems Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Hybrid Positron Emission Tomography (PET) Systems Sales by Country: 2021 VS 2025 VS 2032 (units) Table 56. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2021-2026) & (units) Table 58. Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Country (2021-2026) Table 59. Global Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2027-2032) & (units) Table 60. Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Country (2027-2032) Table 61. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Market Share by Country (2021-2026) Table 63. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Market Share by Country (2027-2032) Table 65. Agfa-Gevaert Group Company Information Table 66. Agfa-Gevaert Group Business Overview Table 67. Agfa-Gevaert Group Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Agfa-Gevaert Group Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 69. Agfa-Gevaert Group Recent Development Table 70. Bruker Company Information Table 71. Bruker Business Overview Table 72. Bruker Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Bruker Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 74. Bruker Recent Development Table 75. Canon Medical Systems Corporation Company Information Table 76. Canon Medical Systems Corporation Business Overview Table 77. Canon Medical Systems Corporation Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Canon Medical Systems Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 79. Canon Medical Systems Corporation Recent Development Table 80. CMR Naviscan Company Information Table 81. CMR Naviscan Business Overview Table 82. CMR Naviscan Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. CMR Naviscan Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 84. CMR Naviscan Recent Development Table 85. Cubresa Company Information Table 86. Cubresa Business Overview Table 87. Cubresa Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Cubresa Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 89. Cubresa Recent Development Table 90. FUJIFILM Holdings Corporation Company Information Table 91. FUJIFILM Holdings Corporation Business Overview Table 92. FUJIFILM Holdings Corporation Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. FUJIFILM Holdings Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 94. FUJIFILM Holdings Corporation Recent Development Table 95. General Electric Company Information Table 96. General Electric Business Overview Table 97. General Electric Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. General Electric Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 99. General Electric Recent Development Table 100. Hitachi Company Information Table 101. Hitachi Business Overview Table 102. Hitachi Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Hitachi Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 104. Hitachi Recent Development Table 105. Koninklijke Philips Company Information Table 106. Koninklijke Philips Business Overview Table 107. Koninklijke Philips Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Koninklijke Philips Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 109. Koninklijke Philips Recent Development Table 110. Mediso Company Information Table 111. Mediso Business Overview Table 112. Mediso Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Mediso Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 114. Mediso Recent Development Table 115. MinFound Medical Systems Company Information Table 116. MinFound Medical Systems Business Overview Table 117. MinFound Medical Systems Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. MinFound Medical Systems Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 119. MinFound Medical Systems Recent Development Table 120. Oncovision Company Information Table 121. Oncovision Business Overview Table 122. Oncovision Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Oncovision Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 124. Oncovision Recent Development Table 125. Rigaku Company Information Table 126. Rigaku Business Overview Table 127. Rigaku Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Rigaku Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 129. Rigaku Recent Development Table 130. Siemens Healthcare Company Information Table 131. Siemens Healthcare Business Overview Table 132. Siemens Healthcare Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Siemens Healthcare Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 134. Siemens Healthcare Recent Development Table 135. Neusoft Corporation Company Information Table 136. Neusoft Corporation Business Overview Table 137. Neusoft Corporation Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Neusoft Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 139. Neusoft Corporation Recent Development Table 140. Medtronic Company Information Table 141. Medtronic Business Overview Table 142. Medtronic Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Medtronic Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 144. Medtronic Recent Development Table 145. Abbott Company Information Table 146. Abbott Business Overview Table 147. Abbott Hybrid Positron Emission Tomography (PET) Systems Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Abbott Hybrid Positron Emission Tomography (PET) Systems Product Portfolio Table 149. Abbott Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Hybrid Positron Emission Tomography (PET) Systems Distributors List Table 153. Hybrid Positron Emission Tomography (PET) Systems Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Hybrid Positron Emission Tomography (PET) Systems Product Image Figure 2. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hybrid Positron Emission Tomography (PET) Systems Sales (2021-2032) & (units) Figure 5. Global Hybrid Positron Emission Tomography (PET) Systems Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Hybrid Positron Emission Tomography (PET) Systems Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Direct Imaging Image Figure 10. Alternative Imaging Image Figure 11. Indirect Imaging Image Figure 12. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 13. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Type (2021-2032) Figure 15. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Diagnostic Imaging Centers Image Figure 20. Others Image Figure 21. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 22. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Application (2021-2032) Figure 24. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application (2021-2032) Figure 27. Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 28. Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032) & (US$ Million) Figure 32. North America Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032) & (US$ Million) Figure 38. South America Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Hybrid Positron Emission Tomography (PET) Systems Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Hybrid Positron Emission Tomography (PET) Systems Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Direct Imaging
  • Alternative Imaging
  • Indirect Imaging
Applications
  • Hospitals
  • Diagnostic Imaging Centers
  • Others
Companies covered
  • Agfa-Gevaert Group
  • Bruker
  • Canon Medical Systems Corporation
  • CMR Naviscan
  • Cubresa
  • FUJIFILM Holdings Corporation
  • General Electric
  • Hitachi
  • Koninklijke Philips
  • Mediso
  • MinFound Medical Systems
  • Oncovision
  • Rigaku
  • Siemens Healthcare
  • Neusoft Corporation
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032)
  4. 1.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume (2021-2032)
  5. 1.2.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hybrid Positron Emission Tomography (PET) Systems Market Dynamics
  1. 2.1 Hybrid Positron Emission Tomography (PET) Systems Industry Trends
  2. 2.2 Hybrid Positron Emission Tomography (PET) Systems Industry Drivers
  3. 2.3 Hybrid Positron Emission Tomography (PET) Systems Industry Opportunities and Challenges
  4. 2.4 Hybrid Positron Emission Tomography (PET) Systems Industry Restraints
3 Hybrid Positron Emission Tomography (PET) Systems Market by Company
  1. 3.1 Global Hybrid Positron Emission Tomography (PET) Systems Company Revenue Ranking in 2025
  2. 3.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue by Company (2021-2026)
  3. 3.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Company (2021-2026)
  4. 3.4 Global Hybrid Positron Emission Tomography (PET) Systems Average Price by Company (2021-2026)
  5. 3.5 Global Hybrid Positron Emission Tomography (PET) Systems Company Ranking (2024-2026)
  6. 3.6 Global Hybrid Positron Emission Tomography (PET) Systems Company Manufacturing Base and Headquarters
  7. 3.7 Global Hybrid Positron Emission Tomography (PET) Systems Company Product Type and Application
  8. 3.8 Global Hybrid Positron Emission Tomography (PET) Systems Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hybrid Positron Emission Tomography (PET) Systems Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hybrid Positron Emission Tomography (PET) Systems Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hybrid Positron Emission Tomography (PET) Systems Market by Type
  1. 4.1 Hybrid Positron Emission Tomography (PET) Systems Type Introduction
  2. 4.1.1 Direct Imaging
  3. 4.1.2 Alternative Imaging
  4. 4.1.3 Indirect Imaging
  5. 4.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Type
  6. 4.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Type
  10. 4.3.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Type (2021-2032)
  12. 4.3.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type (2021-2032)
5 Hybrid Positron Emission Tomography (PET) Systems Market by Application
  1. 5.1 Hybrid Positron Emission Tomography (PET) Systems Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Diagnostic Imaging Centers
  4. 5.1.3 Others
  5. 5.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Application
  6. 5.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Application
  10. 5.3.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Application (2021-2032)
  12. 5.3.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application (2021-2032)
6 Hybrid Positron Emission Tomography (PET) Systems Regional Sales and Value Analysis
  1. 6.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region: 2021-2026
  4. 6.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region (2027-2032)
  5. 6.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Region (2027-2032)
  9. 6.5 Global Hybrid Positron Emission Tomography (PET) Systems Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032)
  12. 6.6.2 North America Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032)
  15. 6.7.2 Europe Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032)
  21. 6.9.2 South America Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Country, 2025 VS 2032
7 Hybrid Positron Emission Tomography (PET) Systems Country-level Sales and Value Analysis
  1. 7.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2021-2032)
  4. 7.3.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2021-2026)
  5. 7.3.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2027-2032)
  6. 7.4 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hybrid Positron Emission Tomography (PET) Systems Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hybrid Positron Emission Tomography (PET) Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agfa-Gevaert Group
  2. 8.1.1 Agfa-Gevaert Group Company Information
  3. 8.1.2 Agfa-Gevaert Group Business Overview
  4. 8.1.3 Agfa-Gevaert Group Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Agfa-Gevaert Group Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  6. 8.1.5 Agfa-Gevaert Group Recent Developments
  7. 8.2 Bruker
  8. 8.2.1 Bruker Company Information
  9. 8.2.2 Bruker Business Overview
  10. 8.2.3 Bruker Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bruker Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  12. 8.2.5 Bruker Recent Developments
  13. 8.3 Canon Medical Systems Corporation
  14. 8.3.1 Canon Medical Systems Corporation Company Information
  15. 8.3.2 Canon Medical Systems Corporation Business Overview
  16. 8.3.3 Canon Medical Systems Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Canon Medical Systems Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  18. 8.3.5 Canon Medical Systems Corporation Recent Developments
  19. 8.4 CMR Naviscan
  20. 8.4.1 CMR Naviscan Company Information
  21. 8.4.2 CMR Naviscan Business Overview
  22. 8.4.3 CMR Naviscan Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CMR Naviscan Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  24. 8.4.5 CMR Naviscan Recent Developments
  25. 8.5 Cubresa
  26. 8.5.1 Cubresa Company Information
  27. 8.5.2 Cubresa Business Overview
  28. 8.5.3 Cubresa Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cubresa Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  30. 8.5.5 Cubresa Recent Developments
  31. 8.6 FUJIFILM Holdings Corporation
  32. 8.6.1 FUJIFILM Holdings Corporation Company Information
  33. 8.6.2 FUJIFILM Holdings Corporation Business Overview
  34. 8.6.3 FUJIFILM Holdings Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 FUJIFILM Holdings Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  36. 8.6.5 FUJIFILM Holdings Corporation Recent Developments
  37. 8.7 General Electric
  38. 8.7.1 General Electric Company Information
  39. 8.7.2 General Electric Business Overview
  40. 8.7.3 General Electric Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 General Electric Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  42. 8.7.5 General Electric Recent Developments
  43. 8.8 Hitachi
  44. 8.8.1 Hitachi Company Information
  45. 8.8.2 Hitachi Business Overview
  46. 8.8.3 Hitachi Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hitachi Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  48. 8.8.5 Hitachi Recent Developments
  49. 8.9 Koninklijke Philips
  50. 8.9.1 Koninklijke Philips Company Information
  51. 8.9.2 Koninklijke Philips Business Overview
  52. 8.9.3 Koninklijke Philips Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Koninklijke Philips Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  54. 8.9.5 Koninklijke Philips Recent Developments
  55. 8.10 Mediso
  56. 8.10.1 Mediso Company Information
  57. 8.10.2 Mediso Business Overview
  58. 8.10.3 Mediso Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Mediso Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  60. 8.10.5 Mediso Recent Developments
  61. 8.11 MinFound Medical Systems
  62. 8.11.1 MinFound Medical Systems Company Information
  63. 8.11.2 MinFound Medical Systems Business Overview
  64. 8.11.3 MinFound Medical Systems Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 MinFound Medical Systems Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  66. 8.11.5 MinFound Medical Systems Recent Developments
  67. 8.12 Oncovision
  68. 8.12.1 Oncovision Company Information
  69. 8.12.2 Oncovision Business Overview
  70. 8.12.3 Oncovision Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Oncovision Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  72. 8.12.5 Oncovision Recent Developments
  73. 8.13 Rigaku
  74. 8.13.1 Rigaku Company Information
  75. 8.13.2 Rigaku Business Overview
  76. 8.13.3 Rigaku Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Rigaku Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  78. 8.13.5 Rigaku Recent Developments
  79. 8.14 Siemens Healthcare
  80. 8.14.1 Siemens Healthcare Company Information
  81. 8.14.2 Siemens Healthcare Business Overview
  82. 8.14.3 Siemens Healthcare Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Siemens Healthcare Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  84. 8.14.5 Siemens Healthcare Recent Developments
  85. 8.15 Neusoft Corporation
  86. 8.15.1 Neusoft Corporation Company Information
  87. 8.15.2 Neusoft Corporation Business Overview
  88. 8.15.3 Neusoft Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Neusoft Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  90. 8.15.5 Neusoft Corporation Recent Developments
  91. 8.16 Medtronic
  92. 8.16.1 Medtronic Company Information
  93. 8.16.2 Medtronic Business Overview
  94. 8.16.3 Medtronic Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Medtronic Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  96. 8.16.5 Medtronic Recent Developments
  97. 8.17 Abbott
  98. 8.17.1 Abbott Company Information
  99. 8.17.2 Abbott Business Overview
  100. 8.17.3 Abbott Hybrid Positron Emission Tomography (PET) Systems Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Abbott Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
  102. 8.17.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hybrid Positron Emission Tomography (PET) Systems Value Chain Analysis
  2. 9.1.1 Hybrid Positron Emission Tomography (PET) Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hybrid Positron Emission Tomography (PET) Systems Sales Mode & Process
  6. 9.2 Hybrid Positron Emission Tomography (PET) Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hybrid Positron Emission Tomography (PET) Systems Distributors
  9. 9.2.3 Hybrid Positron Emission Tomography (PET) Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst